These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
28. Radionuclide therapy for hepatocellular carcinoma: indication, cost and efficacy. Bal CS; Kumar A Trop Gastroenterol; 2008; 29(2):62-70. PubMed ID: 18972764 [TBL] [Abstract][Full Text] [Related]
29. Treatment with (90)Y- and (177)Lu-DOTATOC in patients with metastatic neuroendocrine tumors. Frilling A; Weber F; Saner F; Bockisch A; Hofmann M; Mueller-Brand J; Broelsch CE Surgery; 2006 Dec; 140(6):968-76; discussion 976-7. PubMed ID: 17188146 [TBL] [Abstract][Full Text] [Related]
30. Uncommon tumors and pseudotumoral lesions of the pancreas. de Juan C; Sanchez M; Miquel R; Pages M; Ayuso JR; Ayuso C Curr Probl Diagn Radiol; 2008; 37(4):145-64. PubMed ID: 18502323 [TBL] [Abstract][Full Text] [Related]
31. Tumor response after [(90)Y-DOTA(0),Tyr(3)]octreotide radionuclide therapy in a transplantable rat tumor model is dependent on tumor size. de Jong M; Breeman WA; Bernard BF; Bakker WH; Visser TJ; Kooij PP; van Gameren A; Krenning EP J Nucl Med; 2001 Dec; 42(12):1841-6. PubMed ID: 11752083 [TBL] [Abstract][Full Text] [Related]
32. [IMPROVEMENTS MADE IN SCINTIGRAPHY: VARIABLE CONTRAST AND PANCREATIC IMAGE, STENOPAIC CHAMBER]. DESGREZ A; KELLERSHOHN C Arch Mal Appar Dig Mal Nutr; 1963 Dec; 52():1280-5. PubMed ID: 14098785 [No Abstract] [Full Text] [Related]
33. Imaging features of pancreatic neoplasms. Ros PR; Mortelé KJ JBR-BTR; 2001; 84(6):239-49. PubMed ID: 11817475 [TBL] [Abstract][Full Text] [Related]
34. [The current possibilities of localization and diagnosis of tumors by means of the scintigraphic method]. Rana SA; Demuynck G; Dunjic A J Belge Radiol; 1967; 50(5):373-96. PubMed ID: 5594566 [No Abstract] [Full Text] [Related]
35. Production of the Auger emitter 119Sb for targeted radionuclide therapy using a small PET-cyclotron. Thisgaard H; Jensen M Appl Radiat Isot; 2009 Jan; 67(1):34-8. PubMed ID: 18990581 [TBL] [Abstract][Full Text] [Related]
36. Malignant insulinomas with hepatic metastases successfully treated with selective internal radiation therapy. Ho KW; Wong CC; Balalla B; Diamond T Clin Endocrinol (Oxf); 2006 Sep; 65(3):410-1. PubMed ID: 16918967 [No Abstract] [Full Text] [Related]
37. [Diagnosis of malignant disorders of the extrahepatic bile ducts, peri-ampullar region and pancreas]. Zwaveling A; Gooszen HG; van de Velde CJ; Vierhout PA Ned Tijdschr Geneeskd; 1981 Jul; 125(28):1123-5. PubMed ID: 7254396 [No Abstract] [Full Text] [Related]
38. Diagnostic imaging approach to gastro-entero-pancreatic carcinomas of neuroendocrine origin - single NET center experience in Poland. Cwikla JB; Nasierowska-Guttmejer A; Jeziorski KG; Cichocki A; Zgliczynski W; Stepień K; Seklecka N; Durlik M; Malkowski B; Walecki J Neuro Endocrinol Lett; 2007 Dec; 28(6):789-800. PubMed ID: 18063942 [TBL] [Abstract][Full Text] [Related]
39. [Primary hyperparathyroidism, adrenal tumors and neuroendocrine tumors of the pancreas--clinical diagnosis and imaging requirements]. Auernhammer CJ; Engelhardt D; Göke B Radiologe; 2003 Apr; 43(4):265-74. PubMed ID: 12721642 [TBL] [Abstract][Full Text] [Related]
40. [A case of pancreatic somatostatinoma]. Barbato A; Roviello F; De Stefano A; Marrelli D; Messano A; Guarnieri A; Pinto E Minerva Chir; 1996 Jun; 51(6):475-9. PubMed ID: 8992398 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]